ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,466, issued on Sept. 30, was assigned to Elanco US Inc. (Greenfield, Ind.).
"IL4/IL13 receptor molecule for veterinary use" was invented by Hangjun Zhan (Foster City, Calif.), Lam Nguyen (Union City, Calif.), Fawn Qian (Burlingame, Calif.) and Shyr Jiann Li (Millbrae, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are various embodiments relating to IL13R/IL4R heterodimeric proteins derived from companion animal species and that bind to IL13 and/or IL4. Such heterodimeric proteins can be used in methods to treat IL13 and/or IL4-induced conditions in companion animals, such as canines, felines, and equines."
The patent was filed on ...